The Effect of Priming new Plastic Spacers with 20 Puffs Salbutamol on Bronchodilator Response in Asthmatic Children
,
Abstract
The static charge on the plastic body of spacers attracts drug aerosols, reducing the drug available for inhalation from plastic spacers. Some instructions exist to decrease the electric charge on plastic spacers, such as priming them with salbutamol (20 puffs) before use. This study investigates whether priming plastic spacer devices with this method can improve the bronchodilator test result.
This study included children with stable mild to moderate asthma. All subjects underwent two pulmonary function tests to evaluate their bronchodilator response on separate days at 24-48 hours intervals. On each day, spirometry was performed at the baseline and 15 min after inhalation of four puffs of salbutamol (100 μg/puff) through either a primed or a new spacer. The change in forced expiratory volume in the first second (FEV1) after inhaling salbutamol was the primary outcome measure.
When the patients used a new spacer, the mean baseline FEV1 (% predicted) and FEV1/FVC (forced vital capacity) were 89.56±11.95 and 86.17±6.87, respectively. However, the mean increase in FEV1 from the baseline was 10.87±8.99 in this group. On the other hand, with the primed spacer, the respective mean baseline FEV1 and FEV1/FVC values were 89.41±12.14 and 85.49±6.76, while it increased by 12.1±11.01 after salbutamol inhalation. There were no significant differences between the techniques regarding the variation in FEV1 before and after bronchodilator use via a new spacer or primed spacer.
Priming new plastic spacers with 20 puffs of salbutamol did not cause additional bronchodilation in asthmatic children, suggesting this practice is inefficient in clinics
2. Lavorini F, Fontana G. Targeting drugs to the airways: the role of spacer devices. Expert Opin Drug Deliv
. 2009;6(1):91-102.
3. McIvor RA, Devlin HM, Kaplan A. Optimizing the Delivery of Inhaled Medication for Respiratory Patients: The Role of Valved Holding Chambers. Can Respir J. 2018;2018:5076259.
4. Dissanayake S, Suggett J. A review of the in vitro and in vivo valved holding chamber (VHC) literature with a focus on the AeroChamber Plus Flow-Vu Anti-static VHC. Ther Adv Respir Dis. 2018;12:1753465817751346.
5. Mitchell J, Nagel M. Valved holding chambers(VHCs) for use with pressurized metered-dose inhalers (pMDIs): a review of causes of inconsistent medication delivery. Prim Care Respir J. 16(4):207-14.
6. Dewsbury NJ, Kenyon CJ, Newman SP. The effect of handling techniques on electrostatic charge on spacer devices: A correlation with in vitro particle size analysis. Int J Pharm. 1996;137(15):261-4.
7. Kenyon CJ, Thorsson L, Borgstr.m L. The effects of static charge in spacer devices on glucocorticosteroid aerosol deposition in asthmatic patients. Eur Respir J. 1998;11(5):606-10.
8. Dompeling E, Oudesluys-Murphy AM, H M Janssens, W Hop. Randomised controlled study of clinical efficacy of spacer therapy in asthma with regard to electrostatic charge. Arch Dis Child. 2001;84(2):178-82.
9. Jürg Barben, Mary Roberts, Colin Robertson. Effect of detergent-coated versus non-coated spacers on bronchodilator response in children with asthma. J Paediatr Child Health. 2003;39(4):270-3.
10. Wildhaber JH, Waterer GW, Hall GL, Summers QA. Reducing electrostatic charge on spacer devices and bronchodilator response. Br J Clin Pharmacol. 2000;50(3):277-80.
| Files | ||
| Issue | Vol 23 No 2 (2024) | |
| Section | Brief Communication | |
| DOI | https://doi.org/10.18502/ijaai.v23i2.15328 | |
| Keywords | ||
| Bronchodilator response Paediatric asthma Plastic spacers Salbutamol | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
